GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Yestar Healthcare Holdings Co Ltd (HKSE:02393) » Definitions » Intrinsic Value: Projected FCF

Yestar Healthcare Holdings Co (HKSE:02393) Intrinsic Value: Projected FCF : HK$1.50 (As of Jun. 04, 2025)


View and export this data going back to 2013. Start your Free Trial

What is Yestar Healthcare Holdings Co Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2025-06-04), Yestar Healthcare Holdings Co's Intrinsic Value: Projected FCF is HK$1.50. The stock price of Yestar Healthcare Holdings Co is HK$0.092. Therefore, Yestar Healthcare Holdings Co's Price-to-Intrinsic-Value-Projected-FCF of today is 0.1.

The historical rank and industry rank for Yestar Healthcare Holdings Co's Intrinsic Value: Projected FCF or its related term are showing as below:

HKSE:02393' s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 0.04   Med: 0.57   Max: 2.61
Current: 0.06

During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Yestar Healthcare Holdings Co was 2.61. The lowest was 0.04. And the median was 0.57.

HKSE:02393's Price-to-Projected-FCF is ranked better than
99.74% of 383 companies
in the Medical Devices & Instruments industry
Industry Median: 1.53 vs HKSE:02393: 0.06

Yestar Healthcare Holdings Co Intrinsic Value: Projected FCF Historical Data

The historical data trend for Yestar Healthcare Holdings Co's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yestar Healthcare Holdings Co Intrinsic Value: Projected FCF Chart

Yestar Healthcare Holdings Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.93 2.18 1.24 1.21 1.50

Yestar Healthcare Holdings Co Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.24 - 1.21 - 1.50

Competitive Comparison of Yestar Healthcare Holdings Co's Intrinsic Value: Projected FCF

For the Medical Devices subindustry, Yestar Healthcare Holdings Co's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yestar Healthcare Holdings Co's Price-to-Projected-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Yestar Healthcare Holdings Co's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Yestar Healthcare Holdings Co's Price-to-Projected-FCF falls into.


;
;

Yestar Healthcare Holdings Co Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get Yestar Healthcare Holdings Co's Free Cash Flow(6 year avg) = HK$325.63.

Yestar Healthcare Holdings Co's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Dec24)*0.8)/Shares Outstanding (Diluted Average)
=(9.5203515959648*325.63228571429+492.836*0.8)/2331.590
=1.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Yestar Healthcare Holdings Co  (HKSE:02393) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Yestar Healthcare Holdings Co's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=0.092/1.4987208947532
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Yestar Healthcare Holdings Co Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Yestar Healthcare Holdings Co's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Yestar Healthcare Holdings Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1, Lane 388, Kang’an Road, Room 1210-1213, 12th Floor, Building T1, Pudong New District, Shanghai, CHN
Yestar Healthcare Holdings Co Ltd is a medical consumables and equipment companies in the PRC. Targeting the booming domestic healthcare industry, Its core business focuses on high margin healthcare consumables and equipment namely, medical imaging products and In Vitro Diagnostic products.
Executives
Hartono James 2101 Beneficial owner
Ubs Group Ag 2201 Interest of corporation controlled by you
Fok Hei Yu (in The Capacity As The Receiver) 2501 Other
Chow Wai Shing Daniel (in The Capacity As The Receiver) 2501 Other
Li Bin 2101 Beneficial owner
Hartono Jeane
Hartono Rico
Fujifilm Corporation 2101 Beneficial owner
Fujifilm Holdings Corporation 2201 Interest of corporation controlled by you

Yestar Healthcare Holdings Co Headlines

No Headlines